Vamorolone

Agamree

40 MG / ML SuspensionCanadaMarketedAuthorised 24 Apr 2026

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Agamree 40 MG/ML Suspension OralSpain · 4000 mg · suspensión oral · Santhera Pharmaceuticals GmbhSame brand
AgamreeEuropean Union · Santhera Pharmaceuticals (Deutschland) GmbHSame brand
AgamreeCroatiaSame brand
AgamreeItaly · Sospensione orale · Santhera Pharmaceuticals (Deutschland) GMBHSame brand
AGAMREE 40 mg/ml suspensie voor oraal gebruikNetherlands · Suspensie voor oraal gebruik · Santhera Pharmaceuticals (Deutschland) GmbHSame brand
AgamreeUnited States · 40MG/ML · suspension · Catalyst PharmsSame brand

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Vamorolone

Agamree

40 MG / ML SuspensionCanadaMarketedAuthorised 24 Apr 2026

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Vamorolone
Strength: 40 MG / ML
Dosage form: Suspension
Route: Oral
Register: Canada (Health Canada)
Status: Marketed
Authorised: 24 Apr 2026
Registration: DIN 02561506
Marketing authorisation holder: Kye Pharmaceuticals INC.
ATC code: H02AB18
Group: Systemic hormonal preparations
Supply: PRESCRIPTION